熱門資訊> 正文

VistaGen任命Nick Tressler为首席财务官

2025-12-01 21:45

Vistagen (VTGN) on Monday announced the appointment of Nick Tressler as Chief Financial Officer (CFO), effective December 1, 2025.
Most recently, he served as CFO of DYNEX Technologies, and before that, he was the CFO at American Gene Technologies International and Senseonics Holdings, Inc. (SENS).

More on VistaGen Therapeutics

Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026
Vistagen Therapeutics, Inc. (VTGN) Q2 2026 Earnings Call Transcript
Vistagen targets NDA submission for fasedienol in mid-2026 as PALISADE-3 study nears data readout
Seeking Alpha’s Quant Rating on VistaGen Therapeutics
Historical earnings data for VistaGen Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。